Matthew Brown, BS
Biological Scientist

Matthew Brown 12-18-19
Matthew Brown is a recent graduate of the University of Florida with a Bachelors of Science in Biochemistry & Molecular Biology. He joined the Brusko Lab in the summer of 2019 as a first-year undergraduate student to study the autoimmune response involving the destruction of pancreatic beta-cells which leads to Type 1 Diabetes (T1D). Matthew’s current work focuses on developing Treg adoptive cellular therapy & monoclonal antibody treatment strategies, as well as using genome-editing to evaluate the roles of T1D candidate genes such as CD226 and SIRPG in disease progression.

 


Publications


Abstracts & Presentations

  • Brown ME, Arnoletti JM, Sachs LK, Nguyen KQ, Lee JJ, Brusko TM. CD226 Human Regulatory T Cells Exhibit Increased Stability Compared to Conventionally Sorted Populations. Poster presented at: 18th Congress of the Immunology of Diabetes Society (IDS); 2021 Nov 1-4; Virtual. (Outstanding Abstract Award Received)
  • Brown ME, Hanbali SR, Gomez Rodriguez LM, Arnoletti JM, Carpenter EB, Brusko TM. Human CD4+CD25+CD226 Regulatory T Cells Demonstrate High Purity and Lineage Stability Following In Vitro Expansion for Adoptive Cell Therapy. Poster presented at: 81st Scientific Sessions of the American Diabetes Association (ADA); 2021 Jun 25-29; Virtual.
  • Sharp RC, Brown ME, Brusko TM. Modeling the SIRPγ and CD47 Pathway in Type 1 Diabetes Pathogenesis. Poster presented at: 2020 Annual Meeting of the Human Islet Research Network (HIRN); 2020 Sep 30 – Oct 02; Virtual.

Fellowships & Awards

  • UF College of Medicine – 2021 University Scholar
  • UF College of Medicine – 2020 University Scholar
  • UF Center for Undergraduate Research – 2020 Emerging Scholar

Contact

Lab: (352) 273-9300

Email: matthewbrown@ufl.edu